Additional Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Florida Lung Asthma and Sleep Specialist
    Celebration FL. 34747-1818
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Bogan Sleep Consultants, LLC
    Columbia SC. 29201-2953
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Univerity of Texas Southwestern Medical Center
    Dallas TX. 75235-6243
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Keck School of Medicine of USC
    Los Angeles CA. 90033
    View Details

  • Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

    Research Centers of America
    McKinney TX. 75071
    View Details

  • Cough Reduction in IPF With Nalbuphine ER

    The Pacific Lung Health Centre - St. Pauls Hospital
    Vancouver V6Z 1Y6
    View Details

  • Cough Reduction in IPF With Nalbuphine ER

    Dynamic Drug Advancement
    Ajax L1S 2J5
    View Details

  • Cough Reduction in IPF With Nalbuphine ER

    Centre for Lung Health Clinic
    Vancouver V5Z 1M9
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    University of Rochester
    Rochester NY. 14642
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    University of Louisville
    Louisville KY. 40202
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Beaumont Hospital, Royal Oak
    Royal Oak MI. 48073
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Indiana University Health
    Indianapolis IN. 46202
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Baylor University Medical Center
    Dallas TX. 75246
    View Details

  • Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Icahn School of Medicine at Mount Sinai
    New York NY. 10029
    View Details

  • 129Xe MRI Cardiopulmonary

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Tulane Medical Center
    New Orleans LA. 45227
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Mayo Clinic
    Rochester MN. 55905
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    University of Kansas Medical Center
    Kansas City KS. 66160
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Hospital of the University of Pennsylvania
    Philadelphia PA. 19104
    View Details

  • Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

    Christopher King, MD
    Falls Church VA. 22042
    View Details